InvestorsHub Logo
Followers 827
Posts 119581
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Tuesday, 05/10/2022 11:28:06 AM

Tuesday, May 10, 2022 11:28:06 AM

Post# of 6095
PFE acquires BHVN for $148.50 cash—a 79% premium to yesterday’s close:

https://finance.yahoo.com/news/pfizer-acquire-biohaven-pharmaceuticals-104500807.html

The nominal deal value is $11.6B.

BHVN shareholders will receive 0.5 shares of a newly formed (as yet unnamed) company that will own BHVN’s non-migraine, early-stage pipeline assets.

Note: PFE already owned the ex-US commercial rights to BHVN's Nurtec-ODT/Vydura by virtue of a deal announced in Nov 2021 (#msg-166695371). Vydura (the EU brand name) was approved for marketing in the EU two weeks ago (#msg-168679769).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PFE News